Mesenchymal Stromal Cell Marker (CD44, CD45, CD90 CD29, CD105) Antibody Panel - Human
Be the first to review this product! Submit a review
|
(15 Publications)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mesenchymal Stromal Cell Marker (CD44, CD45, CD90 CD29, CD105) Antibody Panel - Human (AB93758)
ab6124 staining CD44 on Human Tissue sections (Skin tumor) by IHC-P. Sections were Formaldehyde fixed and subjected to heat mediated antigen retrieval in citric acid prior to blocking with 10% serum for 30 mins at 25°C. The primary antibody was diluted 1/100 in PBS and incubated with the sample overnight at 4°C. A TRITC non-Abcam secondary antibody was used.
Product details
Mesenchymal Stromal Cell Marker (CD44, CD45, CD90 CD29, CD105) Antibody Panel ab93758 contains multiple trial-sized versions of clones against key human mesenchymal stromal cell markers, and includes a CD44 mouse monoclonal, CD45 rabbit polyclonal, CD90 mouse monoclonal, CD29 rabbit monoclonal and CD105 mouse monoclonal antibody.
For guidelines on how to use each antibody within the panel, please consult the individual datasheet for each antibody.
Panel contains:
Anti-CD44 antibody [F10-44-2] (ab6124)
Anti-CD45 antibody - Hematopoietic Stem Cell Marker (ab10559)
Anti-CD90 / Thy1 antibody [AF-9] (ab23894)
Anti-CD105 antibody [105C02] (ab44967)
Recombinant Anti-Integrin beta 1 antibody [EP1041Y] (ab52971)
The Human Multipotent Mesenchymal Stromal Cell Marker Antibody Panel is designed for the characterization of cultured or isolated human multipotent mesenchymal stromal cells. The panel contains a group of antibodies for the positive (CD105, CD29, CD44, CD90) and negative (CD45) selection of this lineage. Multipotent mesenchymal stromal cells (MSCs) represent a heterogeneous subset of stromal cells. They can be bone marrow-derived or isolated from many other different adult tissues including periosteum, trabecular bone, adipose tissue, and synovium. They exhibit the potential to give rise to cells of diverse lineages including adipocytes, chondrocytes and osteocytes.
designed to provide you with a variety of trial-size antibodies in a convenient and cost-effective format.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Acta haematologica 146:505-517 PubMed36327876
2022
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2022:2799844 PubMed36117725
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 11:3687-3699 PubMed35441482
2022
Applications
Unspecified application
Species
Unspecified reactive species
Adipocyte 10:493-504 PubMed34699309
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2021:6644366 PubMed34394357
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32839392
2020
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineering (Basel, Switzerland) 7: PubMed32380789
2020
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 10:302 PubMed31623669
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 15:4457-4464 PubMed29731830
2018
Applications
Unspecified application
Species
Unspecified reactive species
European cells & materials 31:296-311 PubMed27227787
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com